Canopy Growth (TSX:WEED) Is Poised to Soar Like Amazon

The long-term outlook for Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is positive despite short-term issues.

| More on:
Business man on stock market financial trade indicator background.

Image source: Getty Images

Cannabis stocks have been some of the hottest investments to own in recent years, many including Canopy Growth (TSX:WEED)(NYSE:CGC) have generated incredible returns. Since going public in April 2014, Canopy has gained a whopping 1,620%, and despite growing concerns over the viability of the legal cannabis industry, there are signs of further growth to come.

As the rough ride endured by online retail behemoth demonstrates, there will always be hiccups for any company operating in an emerging industry. Even after the tech bust, global financial crisis, European sovereign debt crisis, and oil crash, it has returned over 116,000%, after allowing for stock splits, since its 1997 IPO.

This highlights that when investing in rapidly emerging transformative industries, it is important to invest in companies that have established a leading long-term position.

Leading global cannabis company

It is here that Canopy’s appeal comes to the fore. The cultivator’s shock fiscal 2019 result was particularly worrying for investors, because its loss ballooned out to a massive $670 million, or 12 times greater than the $54 million loss reported a year earlier. The fear among major shareholders, including liquor giant Constellation Brands, is that Canopy will be unprofitable, despite it being the world’s largest publicly listed cultivator and the significant growth forecast for global marijuana sales.

Those fears are being fanned by disparate analyst forecasts regarding the size of the global legal cannabis market, which has been estimated to be worth as much as US$155 billion or as little as US$40 billion. That degree of uncertainty doesn’t sit well with investors.

Nonetheless, what is undeniable is that the legal cannabis industry is here to stay and will continue to expand at a decent clip.

Canopy, as the world’s largest publicly listed cannabis cultivator, has developed a global reach through a series of acquisitions and distribution agreements. It has established cultivation operations in Canada, Colombia, Germany, and South Africa as well as an important springboard into the U.S. for when the federal government legalizes the plants use. Canopy has done this by establishing an agreement to acquire U.S. multi-state cannabis company Acreage Holdings when the general cultivation, distribution, and possession of marijuana is federally permitted.

Another worrying issue is Canopy’s high production costs and lack of profitability. For fiscal 2019, it reported total cost of sales of $5.65 per gram of cannabis sold, whereas production costs were $7.21 per gram before adjustments. These are significantly higher than many other cultivators, including Aphria, which reported fiscal third-quarter 2019 all-in cost of sales of $3.76 per gram. This highlights that Canopy needs to work fast to reduce costs and boost profitability.

Despite the doom and gloom, Canopy is likely to be one of the very few industry survivors to perform strongly after the cannabis bubble bursts. This is because of its first-mover advantage and growing economic moat in an industry with few significant barriers to entry. Canopy has built state-of-the-art cultivating and processing facilities, established a global distribution network, and registered 90 patents with another 240 applications underway.

Canopy also doubled down on Colombia, which is a low-cost jurisdiction where analysts estimate that the production costs will be around $0.50 per gram of dried flower. In June 2019, Canopy disclosed that it had roughly tripled its licensed cultivating area to 13.6 million square feet and had entered an agreement with Colombian pharmaceutical company Procaps to develop cannabis oil-based products. This coupled with other initiatives will lead to lower costs.

After finishing fiscal 2019 with $2.5 billion in cash, Canopy has more than enough capital to continue developing its operations.

Foolish takeaway

For these reasons, Canopy will emerge as the leading legal cannabis producer, despite the current issues that have sparked concern among investors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor Matt Smith has no position in any of the stocks mentioned. David Gardner owns shares of Amazon. The Motley Fool owns shares of Amazon.

More on Cannabis Stocks

Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.
Cannabis Stocks

Canopy Growth: Is There Budding Potential in the Cannabis Market?

Canopy Growth stock hit 52-week lows recently on news of needing to re-file on its BIoSteel business, so what now?

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

What’s Happening With Cannabis Stocks in May 2023?

Cannabis stocks were up this week, as the market began to turn, but how long will it last, and is…

Read more »

Cannabis smoke
Cannabis Stocks

Are Cannabis Stocks a Good Buy in May 2023?

If you're going to buy cannabis stocks, these are pretty much the only two I would consider. Even so, you…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Aurora Cannabis: Time to Light Up Your Portfolio?

Here's my take on whether Aurora Cannabis (TSX:ACB) is worth adding to a growth portfolio right now, given its growth…

Read more »

Target. Stand out from the crowd
Tech Stocks

These Undervalued TSX Stocks Are a Bargain in May 2023

If you're willing to bet on a rebound, these are the three TSX stocks I would consider first as they…

Read more »

A cannabis plant grows.
Cannabis Stocks

Tilray Stock Is Scraping 52-Week Lows: Will it Bottom Out Soon?

Tilray (TSX:TLRY) stock remains down 53% in the last year, but when will this company hit the bottom and start…

Read more »

Medicinal research is conducted on cannabis.
Metals and Mining Stocks

2 Canadian Stocks That Are Simply Too Cheap to Avoid

These two Canadian stocks have sunk lower and lower, which is why now could be the right time for long-term…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

1 Marijuana Stock I’d Buy Over Aurora Cannabis

Explore a promising marijuana stock that outshines Aurora Cannabis. Unveil the investment opportunity to boost your cannabis portfolio.

Read more »